Integrative immunogenomic analysis reveals transcriptional and immune-related differences in hepatocellular carcinoma patients with different disease-free survival.

Yang, Xueling; Lei, Guanglin; Wang, Junxiao; Wen, Zhenyu; Ma, Zhenhu; Zhao, Yun; Ren, Hui; Xie, Hui

Yang, Xueling; Lei, Guanglin; Wang, Junxiao; Wen, Zhenyu; Ma, Zhenhu; Zhao, Yun; Ren, Hui; Xie, Hui.

Afiliação

Yang X; Department of Interventional Therapy, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy Tianjin 300060, China.
Lei G; Fifth Medical Center of Chinese PLA General Hospital Beijing 100039, China.
Wang J; Department of Occupational and Environmental Health, School of Public Health, Jilin University Changchun 130000, Jilin, China.
Wen Z; Department of Occupational and Environmental Health, School of Public Health, Jilin University Changchun 130000, Jilin, China.
Ma Z; Fifth Medical Center of Chinese PLA General Hospital Beijing 100039, China.
Zhao Y; Fifth Medical Center of Chinese PLA General Hospital Beijing 100039, China.
Ren H; Fifth Medical Center of Chinese PLA General Hospital Beijing 100039, China.
Xie H; Fifth Medical Center of Chinese PLA General Hospital Beijing 100039, China.

Am J Cancer Res ; 12(4): 1752-1765, 2022.

Article em En | MEDLINE | ID: mdl-35530269

Palavras-chave

Hepatocellular carcinoma (HCC); immune; integrated multiomics analysis; neoantigen

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Am J Cancer Res Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China País de publicação: Estados Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google